| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/29/2011 | CN102112878A Device for detection of influenza virus |
| 06/29/2011 | CN102112611A Novel protease and use thereof |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112492A Diagnosis and treatment of cancer using anti-GPR49 antibody |
| 06/29/2011 | CN102112491A Anti-CD8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory CD8+t cells |
| 06/29/2011 | CN102112490A Notch1受体结合剂和其使用方法 Notch1 receptor binding agents and their use |
| 06/29/2011 | CN102112489A Anti-HEPCIDIN-25 selective antibodies and uses thereof |
| 06/29/2011 | CN102112488A Vaccine against amyloid folding intermediate |
| 06/29/2011 | CN102112155A Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 06/29/2011 | CN102112154A IL-1alpha abs and methods of use |
| 06/29/2011 | CN102112150A Yeast strain for the production of proteins with terminal alpha-1, 3-linked galactose |
| 06/29/2011 | CN102109516A Clenbuterol hydrochloride detection kit for polyclonal antibody |
| 06/29/2011 | CN102108355A Multi-epitope artificial antigen of plasmodium falciparum and application thereof |
| 06/29/2011 | CN101124249B Human monoclonal antibodies to prostate specific membrane antigen(PSMA) |
| 06/28/2011 | US7968696 Viral interleukin-6 |
| 06/28/2011 | US7968690 Agonist anti-trkC antibodies and methods using same |
| 06/28/2011 | US7968689 Antibodies to HSDEK49 polypeptides |
| 06/28/2011 | US7968688 Antibodies that bind to the C35 polypeptide |
| 06/28/2011 | US7968686 Glucagon receptor antagonists |
| 06/28/2011 | US7968684 Polypeptides comprising antigen binding domains for diagnosis, prevention and treatment of inflammation, skin, respiratory, kidney, cardiovascular, nervous system and pancreatic disorder |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968678 Glial mitogenic factors, their preparation and use |
| 06/28/2011 | US7968313 Selection of cells expressing heteromeric polypeptides |
| 06/28/2011 | US7968307 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/28/2011 | US7968303 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1) |
| 06/28/2011 | US7968297 Hyperimmune serum-reactive antigen for use in prevention and treatment of tumor, allergen or metabolic disorders |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | US7968100 Surface proteins from coagulase-negative staphylococci and Staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 06/28/2011 | US7968099 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 06/28/2011 | US7968094 Use of anti-tissue factor antibodies for treating thromboses |
| 06/28/2011 | US7968093 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 06/28/2011 | US7968092 Human binding molecule against CD1a |
| 06/28/2011 | CA2550264C Method and device for detecting feline immunodeficiency virus |
| 06/28/2011 | CA2470656C Corticotropin releasing factor 2 receptor agonists |
| 06/28/2011 | CA2414772C Prevention and treatment of alzheimer's disease |
| 06/28/2011 | CA2331641C Multivalent antibody constructs |
| 06/28/2011 | CA2315976C Serine protease inhibitors |
| 06/28/2011 | CA2309783C Fibroblast growth factor-19 |
| 06/28/2011 | CA2259944C Melanoma associated peptide analogues and vaccines against melanoma |
| 06/28/2011 | CA2222747C Dna sequence and encoded mammary-specific breast cancer protein |
| 06/28/2011 | CA2209300C Redirection of cellular immunity by receptor chimeras |
| 06/28/2011 | CA1341617C Inhibin isolated from ovarian follicular fluid |
| 06/23/2011 | WO2011075606A2 Hyperglycosylated polypeptide variants and methods of use |
| 06/23/2011 | WO2011075578A1 Methods of treating interstitial cystitis |
| 06/23/2011 | WO2011074965A1 Methods and means for counteracting an activity of an fc domain |
| 06/23/2011 | WO2011074802A2 Kit for diagnosing prostate cancer and diagnosis method |
| 06/23/2011 | WO2011074651A1 Cystatin c, β2 microglobulin, α1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy |
| 06/23/2011 | WO2011073954A2 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof |
| 06/23/2011 | WO2011073943A1 Antibodies directed against the transferrin receptor and uses thereof for immunotherapy of iron-dependent tumours |
| 06/23/2011 | WO2011073517A1 Method of distinguishing undifferentiated mesenchymal stem cells and differentiated mesenchymal stem cells from each other by using an antibody against the blood group i antigen |
| 06/23/2011 | WO2011073389A1 Wash solution and method for affinity chromatography |
| 06/23/2011 | WO2011073180A1 Single variable domain antibodies against ox40l, constructs and therapeutic use |
| 06/23/2011 | WO2011045573A3 Staphylococcal antigens |
| 06/23/2011 | WO2011039368A3 Dll4-binding molecules |
| 06/23/2011 | WO2010077473A8 Monoclonal antibodies that react with the capsule of bacillus anthracis |
| 06/23/2011 | WO2003056914A9 Methods to engineer mammalian-type carbohydrate structures |
| 06/23/2011 | US20110154530 Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof |
| 06/23/2011 | US20110154527 Soybean Gene for Resistance to Aphis Glycines |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110154520 Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives |
| 06/23/2011 | US20110152505 Method for decreasing immunogenicity |
| 06/23/2011 | US20110152504 CD16A Binding Proteins and Use for the Treatment of Immune Disorders |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152357 Micro-RNA-Based Compositions and Methods for the Diagnosis, Prognosis and Treatment of Multiple Myeloma |
| 06/23/2011 | US20110152199 Cdca1 peptide and pharmaceutical agent comprising the same |
| 06/23/2011 | US20110152107 Drug Screening Via Nanpore Silicon Filters |
| 06/23/2011 | US20110152106 Cst1, dcc1, ifitm1 or melk as markers for diagnosing stomach cancer |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110151538 Affinity purification by cohesin-dockerin interaction |
| 06/23/2011 | US20110151521 cDNA SYNTHESIS IMPROVEMENTS |
| 06/23/2011 | US20110151490 Compositions for the Detection and Treatment of Colorectal Cancer |
| 06/23/2011 | US20110151489 Monitoring skin metabolism products for evaluating burn injury |
| 06/23/2011 | US20110151483 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1 |
| 06/23/2011 | US20110151473 Polynucleotides and Polypeptides Encoding Receptors |
| 06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
| 06/23/2011 | US20110151451 Use of Conjugates with linkers cleavable by photodissociation or fragmentation for mass spectromety analysis of tissue sections |
| 06/23/2011 | US20110151053 Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore |
| 06/23/2011 | US20110150982 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 06/23/2011 | US20110150928 Unique avian reoviridae |
| 06/23/2011 | US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150913 Torque teno virus (ttv) isolates and compositions |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150907 Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents |
| 06/23/2011 | US20110150906 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 06/23/2011 | US20110150903 Fgf-r4 receptor-specific antagonists |
| 06/23/2011 | US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho |
| 06/23/2011 | US20110150898 EPHA2 as a therapeutic target for cancer |
| 06/23/2011 | US20110150896 Antibody against PCRV |
| 06/23/2011 | US20110150895 Antibody specifically binding to angiopoietin-2 and use thereof |
| 06/23/2011 | US20110150893 Anti-trkb monoclonal antibodies and uses thereof |
| 06/23/2011 | US20110150892 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof |
| 06/23/2011 | US20110150889 Haemophilus influenzae type iv pili |
| 06/23/2011 | US20110150888 Anti-hepcidin antibodies and methods of use |
| 06/23/2011 | US20110150887 Methods and products relating to gsk3beta regulation |
| 06/23/2011 | US20110150886 Anti-areg/hb-egf antibodies and treatment |
| 06/23/2011 | US20110150885 Aminoacyl trna synthetases for modulating hematopoiesis |
| 06/23/2011 | US20110150884 Crystalline composition of gm-csf/gm-csfr |
| 06/23/2011 | US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer |